Clinical trial
Tamoxifen Following Combination Chemotherapy in Treating Women With Operable…
NCT00002579 · Scottish Cancer Therapy Network, Other · Completed
Key facts
| NCT number | NCT00002579 |
|---|---|
| Title | Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer |
| Official title | PROTOCOL FOR THE SCOTTISH CHEMO-ENDOCRINE TRIAL D |
| Lead sponsor | Scottish Cancer Therapy Network, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | CMF regimen, cyclophosphamide, fluorouracil, methotrexate, tamoxifen citrate, conventional surgery, radiation therapy |
| Enrollment | 2,000 |
| Start date | Mar 1, 1993 |
| First posted | Aug 23, 2004 |
| Last update posted | Nov 6, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: